New Zealand markets closed

Entrada Therapeutics, Inc. (TRDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.59-0.15 (-0.95%)
At close: 04:00PM EDT
15.59 0.00 (0.00%)
After hours: 04:25PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
23,485
-6,685
-94,616
-51,158
-26,523
-
Depreciation & amortisation
3,234
2,841
1,895
1,117
326
-
Stock-based compensation
14,089
13,111
9,895
2,526
325
-
Change in working capital
-122,344
136,315
-11,111
-3,421
282
-
Accounts payable
-3,994
-2,805
5,287
-715
631
-
Other working capital
-93,899
134,189
-96,673
-55,442
-27,888
-
Other non-cash items
-
-
-
-
-
-6,273
Net cash provided by operating activities
-89,115
139,803
-93,786
-50,862
-25,570
-
Cash flows from investing activities
Investments in property, plant and equipment
-4,784
-5,614
-2,887
-4,580
-2,318
-
Purchases of investments
-402,366
-407,207
-221,977
0
-
-
Sales/maturities of investments
335,346
274,426
76,214
0
-
-
Net cash used for investing activities
-71,804
-138,395
-148,650
-4,580
-2,318
-
Cash flows from financing activities
Common stock issued
0
19,407
0
190,691
0
-
Net cash used provided by (used for) financing activities
1,707
21,037
479
307,461
50,089
-
Net change in cash
-159,212
22,445
-241,957
252,019
22,201
-
Cash at beginning of period
231,598
49,107
291,064
39,045
16,844
-
Cash at end of period
72,386
71,552
49,107
291,064
39,045
-
Free cash flow
Operating cash flow
-89,115
139,803
-93,786
-50,862
-25,570
-
Capital expenditure
-4,784
-5,614
-2,887
-4,580
-2,318
-
Free cash flow
-93,899
134,189
-96,673
-55,442
-27,888
-